Bruno Melillo

34PUBLICATIONS
166CO-AUTHORS
ChemotherapyNanotoxicology, health and safetyCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 28, 2026
An enantioselective covalent inhibitor of BAX confers cytoprotection in vivo.

|Jun 18, 2026
Minimum Inoculum of Resistance Assay for Evaluating Antitoxoplasmosis Compounds That Target Phenylalanine tRNA Synthetase.

|May 20, 2026
A Global Ligandability Map of Tryptoline Butynamide Stereoprobes Identifies Covalent Inhibitors of the Actin Maturation Protease.

|Feb 16, 2026
High-throughput ligand diversification to discover chemical inducers of proximity.

James B Shaum, Miquel Muñoz I Ordoño, Erica A Steen

|Feb 03, 2026
Targeting extrachromosomal DNA in human cancers.

Ivy Tsz-Lo Wong, Hyerim Yi, Bruno Melillo

|Jan 28, 2026
Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.

Arthur S Kim, Kevin Ma, Christopher J Reinhardt

Pageof 6

Frequent Collaborators

20 joint publications

Benjamin F Cravatt

12 joint publications

Stuart L Schreiber

5 joint publications

L David Sibley

4 joint publications

Guoqin Xia